Harvard Colon Chip Shows Fibroblasts Trigger IBD Damage and Raise Colorectal Cancer Risk
Updated
Updated · ScienceAlert · Jul 20
Harvard Colon Chip Shows Fibroblasts Trigger IBD Damage and Raise Colorectal Cancer Risk
2 articles · Updated · ScienceAlert · Jul 20
Summary
Nature Biomedical Engineering published a Harvard-led study showing patient-derived fibroblasts alone could make healthy intestinal cells behave like IBD tissue, weakening the gut barrier and intensifying inflammatory responses.
The Colon Chip combines matched epithelial cells, stromal fibroblasts, immune cells and peristalsis-like mechanical forces, giving researchers a more complete human model than conventional cell cultures or animal systems.
Pregnancy-related hormones and bowel-motion stretching both amplified inflammatory and fibrotic responses in chips built from IBD tissue, helping explain disease flare-ups and scarring.
ENU carcinogen tests showed diseased chips developed much stronger early cancer-linked molecular changes, and healthy tissue began expressing those markers only after exposure to fibroblasts from IBD patients.
The findings suggest fibroblasts are active drivers of IBD progression and colorectal cancer susceptibility, offering a platform to study mechanisms that have been hard to isolate in human tissue.
This gut chip shows how IBD can lead to cancer. What other disease mysteries could this technology solve next?
Could targeting connective tissue, not just immune cells, finally lead to a cure for inflammatory bowel disease?
As new laws phase out animal testing, will personalized 'organ chips' become the standard for developing safer drugs?
Patient-Derived Fibroblasts Drive IBD Progression and Cancer Risk: A Colon Chip Breakthrough
Overview
A landmark study from Harvard's Wyss Institute, published in 2026, used an advanced colon-on-a-chip model to reveal that patient-derived stromal fibroblasts are not just structural cells, but active drivers of inflammatory bowel disease (IBD) and its link to colorectal cancer. The research showed that fibroblasts from IBD patients can trigger disease-like changes in healthy colon epithelial cells, leading to increased inflammation, impaired barrier function, and higher cell growth. This discovery challenges old views and highlights fibroblasts as central players in disease progression, opening new paths for understanding and treating IBD and cancer.